ACLU suing FDA over abortion pill REMS

The American Civil Liberties Union filed a suit in the U.S. District Court for the District of Hawaii against FDA challenging the REMS program for abortion drug Mifeprex mifepristone (RU-486).

According to the suit, the REMS restricts access to the progestin antagonist by making it available only directly from a healthcare provider who has pre-registered with the drug manufacturer Danco Laboratories LLC (New York, N.Y.) to have the pill ordered and stocked in its medical facility. The ACLU said the restrictions delay and in some cases prevent a woman's access to abortion. The ACLU hopes to make Mifeprex available through a pharmacy by prescription...